Pyxis Oncology Inc (PYXS)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
CEO:
Lara Sullivan
Employees:
800 BOYLSTON STREET, SUITE 1555, BOSTON, MA 02199
(617) 351-2575

We are a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. We develop our product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. We were incorporated in the state of Delaware on June 11, 2018 and launched with our first employee and Series A funding in July 2019. Our principal executive offices are located at 35 CambridgePark Drive Cambridge, Massachusetts.

Data derived from most recent annual or quarterly report
Market Cap 72.736 Million Shares Outstanding32.764 Million Avg 30-day Volume 265.82 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.93
Price to Revenue0.0 Debt to Equity0.0 EBITDA-75.12 Million
Price to Book Value1.3787 Operating Margin0.0 Enterprise Value84.067 Million
Current Ratio14.896 EPS Growth0.281 Quick Ratio14.685
1 Yr BETA 0.9571 52-week High/Low 19.0 / 1.96 Profit Margin0.0
Operating Cash Flow Growth-250.3173 Altman Z-Score11.3172 Free Cash Flow to Firm -34.684 Million
Earnings Report2022-08-12

View recent insider trading info

Funds Holding PYXS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PYXS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

1.7 Million total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BARCLAYS PLC

  • 10% Owner
0 2022-04-26 2

CHIN MARK

  • FORMER DIRECTOR
0 2022-04-21 4

SULLIVAN LARA CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,356,636 2022-04-14 3

YANCHIK CONNEALY PAMELA CHIEF FINANCIAL OFFICER

  • Officer
341,017 2022-04-14 3

FEINGOLD JAY CHIEF MEDICAL OFFICER

  • Officer
466,611 2022-04-14 3

FLAVIN JOHN L

238,441 2022-03-31 3

LEWIS-HALL FREDA C

66,831 2022-03-31 2

CLINE DARREN S

76,831 2022-03-31 3

CIVIK THOMAS

82,531 2022-03-31 3

BAYER WORLD INVESTMENTS B.V.

BAYER AKTIENGESELLSCHAFT

  • FORMER 10% OWNERFORMER 10% OWNER
2,742,338 2021-10-13 1

CORMORANT ASSET MANAGEMENT, LP

CHEN BIHUA

CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

CORMORANT PRIVATE HEALTHCARE FUND III LP

  • Director
  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
1,787,708 2021-10-13 1

SHAH RITU CHIEF OPERATING OFFICER

31,344 2021-10-07 1

HERBST RONALD CHIEF SCIENTIFIC OFFICER

28,252 2021-10-07 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

CHIN MARK FORMER DIRECTOR see footnote

2022-04-25 12:12:03 -0400 2022-04-21 S 1,745,761 $3.05 d 0 indirect -3.6101 -7.9422 0.0 1 -11.5523 5

YANCHIK CONNEALY PAMELA - Officer CHIEF FINANCIAL OFFICER

2022-04-15 20:00:03 -0400 2022-04-14 A 93,493 a 341,017 direct -0.641 -11.2179 0.0 1 -15.0641 4

FEINGOLD JAY - Officer CHIEF MEDICAL OFFICER

2022-04-15 19:58:23 -0400 2022-04-14 A 115,931 a 466,611 direct -0.641 -11.2179 0.0 1 -15.0641 4

SULLIVAN LARA - Director - Officer CHIEF EXECUTIVE OFFICER

2022-04-15 19:56:52 -0400 2022-04-14 A 315,273 a 1,356,636 direct -0.641 -11.2179 0.0 1 -15.0641 4

FEINGOLD JAY CHIEF MEDICAL OFFICER

2022-04-04 16:16:03 -0400 2022-03-31 A 306,930 a 350,680 direct 7.9179 31.6716 -40.176 32.8446 7 -40.7625 28

LEWIS-HALL FREDA C

2022-04-04 16:15:36 -0400 2022-03-31 A 66,831 a 66,831 direct 7.9179 31.6716 -40.176 32.8446 7 -40.7625 28

CHIN MARK

2022-04-04 16:15:47 -0400 2022-03-31 A 66,831 a 66,831 direct 7.9179 31.6716 -40.176 32.8446 7 -40.7625 28

YANCHIK CONNEALY PAMELA CHIEF FINANCIAL OFFICER

2022-04-04 16:15:42 -0400 2022-03-31 A 247,524 a 247,524 direct 7.9179 31.6716 -40.176 32.8446 7 -40.7625 28

CLINE DARREN S

2022-04-04 16:15:47 -0400 2022-03-31 A 66,831 a 76,831 direct 7.9179 31.6716 -40.176 32.8446 7 -40.7625 28

CIVIK THOMAS

2022-04-04 16:15:52 -0400 2022-03-31 A 66,831 a 66,831 direct 7.9179 31.6716 -40.176 32.8446 7 -40.7625 28

FLAVIN JOHN L

2022-04-04 16:16:05 -0400 2022-03-31 A 66,831 a 238,441 direct 7.9179 31.6716 -40.176 32.8446 7 -40.7625 28

SULLIVAN LARA CHIEF EXECUTIVE OFFICER

2022-04-04 16:15:53 -0400 2022-03-31 A 742,574 a 1,041,363 direct 7.9179 31.6716 -40.176 32.8446 7 -40.7625 28

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
PYXIS ONCOLOGY INC PYXS 2022-05-20 22:15:03 UTC -4.4872 5.3072 20000
PYXIS ONCOLOGY INC PYXS 2022-05-20 21:45:03 UTC -4.4872 5.3072 20000
PYXIS ONCOLOGY INC PYXS 2022-05-20 21:15:03 UTC -4.4872 5.3072 20000
PYXIS ONCOLOGY INC PYXS 2022-05-20 20:45:03 UTC -4.7074 5.5274 20000
PYXIS ONCOLOGY INC PYXS 2022-05-20 20:15:05 UTC -4.7074 5.5274 20000
PYXIS ONCOLOGY INC PYXS 2022-05-20 19:45:03 UTC -4.7074 5.5274 20000
PYXIS ONCOLOGY INC PYXS 2022-05-20 19:15:04 UTC -4.7074 5.5274 20000
PYXIS ONCOLOGY INC PYXS 2022-05-20 18:45:03 UTC -5.4391 6.2591 20000
PYXIS ONCOLOGY INC PYXS 2022-05-20 18:15:03 UTC -5.4391 6.2591 20000
PYXIS ONCOLOGY INC PYXS 2022-05-20 17:45:03 UTC -5.4391 6.2591 20000
PYXIS ONCOLOGY INC PYXS 2022-05-20 17:15:03 UTC -5.4391 6.2591 20000
PYXIS ONCOLOGY INC PYXS 2022-05-20 16:45:04 UTC -5.1761 5.9961 20000
PYXIS ONCOLOGY INC PYXS 2022-05-20 16:15:03 UTC -5.1761 5.9961 20000
PYXIS ONCOLOGY INC PYXS 2022-05-20 15:45:03 UTC -5.1761 5.9961 20000
PYXIS ONCOLOGY INC PYXS 2022-05-20 15:15:03 UTC -5.1761 5.9961 20000
PYXIS ONCOLOGY INC PYXS 2022-05-20 14:45:03 UTC -6.4506 7.2706 20000
PYXIS ONCOLOGY INC PYXS 2022-05-20 14:15:04 UTC -6.4506 7.2706 20000
PYXIS ONCOLOGY INC PYXS 2022-05-20 13:45:03 UTC -6.4506 7.2706 20000
PYXIS ONCOLOGY INC PYXS 2022-05-20 13:15:03 UTC -6.4506 7.2706 20000
PYXIS ONCOLOGY INC PYXS 2022-05-20 12:45:03 UTC -6.4506 7.2706 20000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund PYXS -342.0 shares, $-3262.68 2022-01-31 N-PORT

Elevate your investments